Akiko Nakayama - Concepedia

Author

Akiko Nakayama

Max Planck Institute for Heart and Lung Research

Also Known As

A Nakayama, A. NAKAYAMA, A. Nakayama, AKIKO NAKAYAMA, Akiko NAKAYAMA, Akiko Nakayama, Nakayama, Akiko

106

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Max Planck Institute for Heart and Lung Research Takeda (Japan)Goethe University Frankfurt National Institute of Diabetes and Digestive and Kidney Diseases Osaka Medical and Pharmaceutical University

About

Akiko Nakayama is an author at Max Planck Institute for Heart and Lung Research specializing in medicine, engineering, and chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	987
2	Engineering	8	8	145
3	Applied Physics	4	4	71
4	Health Sciences	1	1	21
5	Natural Sciences	1	1	12

Akiko Nakayama

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Spatial regulation of VEGF receptor endocytosis in angiogenesis Masanori Nakayama, Akiko Nakayama, Max van Lessen, Nature Cell Biology AngiogenesisMorphogenesisVascular BiologyNeovascularizationVascular Endothelial Growth Factor	2013	269
Design and Synthesis of Novel Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors Bearing a Pyrrolo[3,2-<i>d</i>]pyrimidine Scaffold Tomoyasu Ishikawa, Masaki Seto, Hiroshi Banno, Journal of Medicinal Chemistry Dual Inhibitors BearingMedicinal ChemistryDual InhibitorsMedicineX-ray Cocrystal Structures	2011	207
Shear stress–induced endothelial adrenomedullin signaling regulates vascular tone and blood pressure András Iring, Young‐June Jin, Julián Albarrán-Juárez, Journal of Clinical Investigation HypertensionNitric OxideEndothelial AdrenomedullinBlood PressureInflammation	2019	201
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells Yoshinori Ishikawa, Kanae Gamo, Masato Yabuki, Molecular Cancer Therapeutics Demethylase 1AMixed-phenotype Acute LeukemiaMyeloid NeoplasiaHematological MalignancySignaling Pathway	2016	103
Functional Dissection of LIS1 and NDEL1 Towards Understanding the Molecular Mechanisms of Cytoplasmic Dynein Regulation Takayuki Torisawa, Akiko Nakayama, Ken’ya Furuta, Journal of Biological Chemistry	2010	61
Ephrin-B2 controls PDGFRβ internalization and signaling Akiko Nakayama, Masanori Nakayama, Christopher J. Turner, Genes & Development	2013	55
Design and Synthesis of Pyrrolo[3,2-<i>d</i>]pyrimidine Human Epidermal Growth Factor Receptor 2 (HER2)/Epidermal Growth Factor Receptor (EGFR) Dual Inhibitors: Exploration of Novel Back-Pocket Binders Youichi Kawakita, Hiroshi Banno, Tomohiro Ohashi, Journal of Medicinal Chemistry	2012	42
aPKC controls endothelial growth by modulating c-Myc via FoxO1 DNA-binding ability Meghan Riddell, Akiko Nakayama, Takao Hikita, Nature Communications	2018	41
Prevalence of the coexistence of left ventricular false tendons and premature ventricular complexes in apparently healthy subjects: A prospective study in the general population Michihiro Suwa, Yuzo Hirota, Kiyotaka Kaku, Journal of the American College of Cardiology CardiomyopathyHeart FailureHealthy SubjectsCardiovascular DiseaseCardiac Mechanic	1988	39
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplication Yoshinori Ishikawa, K. Nakayama, Megumi Morimoto, Oncogenesis	2017	38

Page 1